Post-PHE Claim Submission Requirements for Continuous Glucose Monitors
Centers for Medicare and Medicaid Services (CMS ) did not enforce clinical indications for specific product categories during the Public Health Emergency (PHE), including Continuous Glucose Monitors (CGMs). During this time, the provider only needed to indicate the CGM and related supplies were reasonable and necessary. Pharmacies had to identify that these claims were excluded from enforcement by submitting a Catastrophe/Disaster Related (CR) modifier and a COVID-19 narrative on those claims.
Now that the PHE has ended and CMS is enforcing clinical indications for CGMs and supplies, pharmacies are left wondering what will happen with continued or refilled claims for CGM related supply items initially provided during the PHE under the waiver/non-enforcement.
PAAS Tips:
- PAAS Defends Community Pharmacies by Engaging DME Medicare Administrative Contractor CGS - September 27, 2023
- Best Practices for Billing Vaginal Creams to Avoid Recoupment - September 23, 2023
- Migraine Medications Continue to Cause Headaches - August 24, 2023